609799-22-6
Chemical Structure
Tasimelteon
Synonym(s): BMS-214778; VEC-162
- CAS No.: 609799-22-6
- Formula:C15H19NO2
- Molecular Weight:245.32
IUPAC Name: N-(((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide
InChIKey: PTOIAAWZLUQTIO-GXFFZTMASA-N
SMILES: [H][C@]1(C2=C3C(OCC3)=CC=C2)[C@@](CNC(CC)=O)([H])C1
Biological Activity: Tasimelteon (BMS-214778) is an orally active and selective dual melatonin receptor agonist (DMRA). Tasimelteon has 2.1-4.4 times greater affinity for the MT2 receptor than for the MT1 receptor. Tasimelteon is a circadian regulator and has the potential for Non-24-Hour Sleep-Wake Disorder (Non-24)[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Tasimelteon | 99.16% | Tasimelteon (BMS-214778) is an orally active and selective dual melatonin receptor agonist (DMRA). Tasimelteon has 2.1-4.4 times greater affinity for the MT2 receptor than for the MT1 receptor. Tasimelteon is a circadian regulator and has the potential for Non-24-Hour Sleep-Wake Disorder (Non-24). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Tasimelteon (Standard) | ≥98% | Tasimelteon (Standard) is the analytical standard of Tasimelteon. This product is intended for research and analytical applications. Tasimelteon (BMS-214778) is an orally active and selective dual melatonin receptor agonist (DMRA). Tasimelteon has 2.1-4.4 times greater affinity for the MT2 receptor than for the MT1 receptor. Tasimelteon is a circadian regulator and has the potential for Non-24-Hour Sleep-Wake Disorder (Non-24). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Tasimelteon-d5 | Tasimelteon-d5 is the deuterium labeled Tasimelteon. Tasimelteon (BMS-214778) is an orally active and selective dual melatonin receptor agonist (DMRA). Tasimelteon has 2.1-4.4 times greater affinity for the MT2 receptor than for the MT1 receptor. Tasimelteon is a circadian regulator and has the potential for Non-24-Hour Sleep-Wake Disorder (Non-24). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.72
HY-75256RRamelteon impurity 10 (Standard) -
Similarity Score 0.72
HY-A0014Ramelteon -
Similarity Score 0.72
HY-I0603(R)-Ramelteon -
Similarity Score 0.67
HY-120623BMS-284640 -
Similarity Score 0.66
HY-103005RRamelteon metabolite M-II (Standard) -
Similarity Score 0.65
HY-I0600Rametimide impurity 16 -
Similarity Score 0.65
HY-75256S(Rac)-Remelteon-d3 -
Similarity Score 0.65
HY-A0014S1Ramelteon-d3 -
Similarity Score 0.63
![(S)-2-(2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethanamine hydrochloride Chemical Structure](//file.medchemexpress.com/product_pic/hy-75074.gif)
HY-75074(S)-2-(2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethanamine hydrochloride -
Explore the MedChemAI to find more analogs
![(S)-2-(2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethanamine hydrochloride Chemical Structure](http://file.medchemexpress.com/product_pic/hy-75074.gif)
